Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, 183, 788, 10.1164/rccm.2009-040GL King, 2014, A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis, N Engl J Med, 370, 2083, 10.1056/NEJMoa1402582 Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N Engl J Med, 370, 2071, 10.1056/NEJMoa1402584 Nishiyama, 2005, Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?, Respir Med, 99, 408, 10.1016/j.rmed.2004.09.005 Swigris, 2005, Health-related quality of life among patients with idiopathic pulmonary fibrosis, Chest, 127, 284, 10.1378/chest.127.1.284 1980, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group, Ann Intern Med, 93, 391, 10.7326/0003-4819-93-3-391 Albert, 2016, A randomized trial of long-term oxygen for COPD with moderate desaturation, N Engl J Med, 375, 1617, 10.1056/NEJMoa1604344 Du Plessis, 2018, Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD, Respirology, 23, 392, 10.1111/resp.13226 Hardinge, 2015, Guideline update: the British Thoracic Society Guidelines on home oxygen use in adults, Thorax, 70, 589, 10.1136/thoraxjnl-2015-206918 Jo, 2018, Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary, Med J Aust, 208, 82, 10.5694/mja17.00799 Bell, 2017, Oxygen therapy for interstitial lung disease: a systematic review, Eur Respir Rev, 26, 160080, 10.1183/16000617.0080-2016 Sharp, 2016, Ambulatory and short-burst oxygen for interstitial lung disease, Cochrane Database Syst Rev, 7 Schaeffer, 2017, Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease, Eur Respir J, 49, 1602494, 10.1183/13993003.02494-2016 Dowman, 2017, Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia, Respirology, 22, 957, 10.1111/resp.13002 Graney, 2017, Looking ahead and behind at supplemental oxygen: a qualitative study of patients with pulmonary fibrosis, Heart Lung, 46, 387, 10.1016/j.hrtlng.2017.07.001 Khor, 2017, Oxygen therapy for interstitial lung disease. A mismatch between patient expectations and experiences, Ann Am Thorac Soc, 14, 888, 10.1513/AnnalsATS.201611-934OC Ryerson, 2016, High oxygen delivery to preserve exercise capacity in patients with idiopathic pulmonary fibrosis treated with nintedanib. Methodology of the HOPE-IPF study, Ann Am Thorac Soc, 13, 1640, 10.1513/AnnalsATS.201604-267OC Visca, 2017, Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial, Trials, 18, 201, 10.1186/s13063-017-1912-9 Leach, 1992, Portable liquid oxygen and exercise ability in severe respiratory disability, Thorax, 47, 781, 10.1136/thx.47.10.781 Holland, 2014, An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease, Eur Respir J, 44, 1428, 10.1183/09031936.00150314 Wells, 2003, Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography, Am J Respir Crit Care Med, 167, 962, 10.1164/rccm.2111053 Borg, 1982, Psychophysical bases of perceived exertion, Med Sci Sports Exerc, 14, 377, 10.1249/00005768-198205000-00012 Ritchie, 1994, Qualitative data analysis for applied policy research, 173 Patel, 2012, The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire, Thorax, 67, 804, 10.1136/thoraxjnl-2012-201581 Eakin, 1998, Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego, Chest, 113, 619, 10.1378/chest.113.3.619 Jones, 1991, The St George's Respiratory Questionnaire, Respir Med, 85, 25, 10.1016/S0954-6111(06)80166-6 Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x Bjelland, 2002, The validity of the Hospital Anxiety and Depression Scale. An updated literature review, J Psychosom Res, 52, 69, 10.1016/S0022-3999(01)00296-3 Mi, 2017, Associations between the psychological health of patients and carers in advanced COPD, Int J Chron Obstruct Pulmon Dis, 12, 2813, 10.2147/COPD.S139188 Patel, 2013, The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease, Respir Med, 107, 1438, 10.1016/j.rmed.2013.06.009 Senn, 2002 Jones, 2014 Koch, 1972, The use of non-parametric methods in the statistical analysis of the two-period change-over design, Biometrics, 28, 577, 10.2307/2556170 Barker, 2017, The King's Brief Interstitial Lung Disease Questionnaire: response to pulmonary rehabilitation and minimal important difference, Am J Respir Crit Care Med, 195, A2849 Manini, 2006, Daily activity energy expenditure and mortality among older adults, JAMA, 296, 171, 10.1001/jama.296.2.171 Horita, 2014, Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego Shortness of Breath Questionnaire, COPD, 11, 26, 10.3109/15412555.2013.808615 Arnold, 2011, Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study, BMC Pulm Med, 11, 9, 10.1186/1471-2466-11-9 Redelmeier, 1997, Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients, Am J Respir Crit Care Med, 155, 1278, 10.1164/ajrccm.155.4.9105067 Carpagnano, 2004, Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation, Thorax, 59, 1016, 10.1136/thx.2003.020768 Wang, 2017, Intermittent hypoxia simulating obstructive sleep apnea causes pulmonary inflammation and activates the Nrf2/HO-1 pathway, Exp Ther Med, 14, 3463, 10.3892/etm.2017.4971 Prabhakar, 2012, Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2, Physiol Rev, 92, 967, 10.1152/physrev.00030.2011 Abernethy, 2010, Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial, Lancet, 376, 784, 10.1016/S0140-6736(10)61115-4 Liss, 1988, The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, 137, 1285, 10.1164/ajrccm/137.6.1285